Molnupiravir
CAS No. 2492423-29-5
Molnupiravir( —— )
Catalog No. M35495 CAS No. 2492423-29-5
Molnupiravir (EIDD-2801) is an isopropyl ester prodrug of the ribonucleoside analog EIDD-1931 with oral bioavailability.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 32 | Get Quote |
|
| 10MG | 52 | Get Quote |
|
| 25MG | 66 | Get Quote |
|
| 50MG | 112 | Get Quote |
|
| 100MG | 177 | Get Quote |
|
| 200MG | 335 | Get Quote |
|
| 500MG | 709 | Get Quote |
|
| 1G | 972 | Get Quote |
|
Biological Information
-
Product NameMolnupiravir
-
NoteResearch use only, not for human use.
-
Brief DescriptionMolnupiravir (EIDD-2801) is an isopropyl ester prodrug of the ribonucleoside analog EIDD-1931 with oral bioavailability.
-
DescriptionMolnupiravir (EIDD-2801) is an orally bioavailable proagent of the ribonucleoside analog EIDD-1931. Molnupiravir has broad spectrum antiviral activity against influenza virus and multiple coronaviruses, such as SARS-CoV-2, MERS-CoV, SARS-CoV. Molnupiravir has the potential for the research of COVID-19, and seasonal and pandemic influenza.
-
In Vitro——
-
In VivoAnimal Model:C57BL/6 mice (intranasal infection with SARS-CoV)Dosage:50, 150, 500 mg/kg Administration:Oral; every 12 hours for 3 days Result:Body weight loss is significantly diminished or prevented.Animal Model: Ca/09-infected female ferrets Dosage:7 mg/kg Administration:Oral; twice daily for 3.5 days Result:Shed virus load and duration of fever were significantly reduced.
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetInfluenza Virus
-
RecptorInfluenza Virus | SARS-CoV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2492423-29-5
-
Formula Weight329.31
-
Molecular FormulaC13H19N3O7
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (151.83 mM; Ultrasonic )H2O : 12.5 mg/mL (37.96 mM; Ultrasonic)
-
SMILESCC(C)C(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cc\c(=N/O)[nH]c1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sheahan TP, et al. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci Transl Med. 2020 Apr 6. pii: eabb5883.?
molnova catalog
related products
-
N-Glycolylneuraminic...
N-Glycolylneuraminic acid is a nonhuman sialic acid molecule synthesized in pigs. N-Glycolylneuraminic acid is a receptor of human and animal IAVs.
-
3-?Phenyl-?N-?[1-?(p...
3-?Phenyl-?N-?[1-?(phenylmethyl)?-?4-?piperidinyl]?-tricyclo[3.3.1.13?7]?decane-?1-?carboxamide with antiviral activity against Ebola virus that targets the surface-exposed glycoprotein and inhibits viral entry into host cells.?In vitro studies in Vero cells revealed the compound inhibits the viral replication with EC50 of 0.38 μM.
-
Oseltamivir phosphat...
A competitive inhibitor of influenza neuraminidase that prevents new viral particles from being released.
Cart
sales@molnova.com